How Combination Chemotherapy Manages Mets
Learn how combination chemotherapy helps senior dog Jake beat the osteosarcoma odds with monthly carboplatin and Palladia doses.
metronomics
Lung Metastasis in Tripawds with Limb Cancer: Now What?
Learn your options for treating lung metastasis in Tripawds with advanced bone cancer, with Dr. Bernard Séguin, DVM, MS, Diplomate ACVS from the Colorado State University Flint Animal Cancer Center.
Tripawd Limb Cancer Treatments with Bisphosphonates, Palladia
Learn about the most common Tripawd limb cancer treatments including bisphosphonates, Palladia (a “targeted therapy) and lung metastasis treatment options, as explained by the Colorado State University Flint Animal Cancer Center’s Dr. Bernard Séguin, DVM, MS, Diplomate ACVS, ACVS Founding Fellow – Surgical Oncology and Associate Professor, Surgical Oncology.
Metronomic Chemotherapy FAQs for Tripawds
If your pet has cancer, read these metronomic chemotherapy FAQs for Tripawds, then discuss this treatment option with your vet oncologist.
The Chemotherapy Decision: Joys and Regrets
Struggling with the chemotherapy decision for your tripawd? See how other parents coped with pet cancer chemotherapy decisions and regrets.
More About Chlorambucil, Cyclophosphamide for Metronomic Chemotherapy
Dr. Joanne Intile DVM, DACVIM/Oncology, explains the use of cyclophosphamide (cytoxan) and chlorambucil (leukeran) in metronomic chemotherapy to help fight dog and cat cancer.
Morris Animal Foundation Studies Metronomic Chemotherapy
Morris Animal Foundation studies metronomic chemotherapy effectiveness for canine amputees with bone cancer and soft tissue sarcomas.
Dr. Rosenberg’s Thoughts on Metronomics and Supplements
Dr. Mona Rosenberg of the Veterinary Cancer Group of Southern California discusses the Metronomic Protocol for canine cancer oncology treatments, and shares her opinion about immune boosting supplements.
My Metronomic Therapy
Discussion of the Metronomic Protocol, K9 Immunity and diet tips for treating pulmonary metastasis in dogs affected with canine osteosarcoma.